Spero Therapeutics Inc. (SPRO)

NASDAQ: SPRO · Real-Time Price · USD

0.65

-0.01 (-1.52%)

At close: May 02, 2025, 11:11 AM

Spero Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	52.89M	76.33M	109.11M	112.58M	85.21M	29.73M	34.08M	87.29M	10.31M
Short-Term Investments	n/a	n/a	n/a	33.82M	41.7M	52.31M	81.36M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	21K	233K	50K	50K
Other Long-Term Assets	153K	47.02M	10.2M	5.64M	17.76M	16.89M	10.44M	4.98M	350K
Receivables	52.48M	50.7M	1.08M	2.64M	6.18M	8.55M	1.3M	2.94M	304K
Inventory	n/a	n/a	-4.46M	n/a	-12.24M	-13.37M	-8.78M	-4.77M	n/a
Other Current Assets	1.91M	4.18M	3.38M	8.83M	6.06M	n/a	7.48M	1.83M	n/a
Total Current Assets	107.28M	131.21M	109.11M	157.87M	126.91M	82.05M	115.44M	87.29M	11.87M
Property-Plant & Equipment	3.11M	4.16M	5.49M	7.56M	8.78M	7.15M	2.89M	1.16M	1.5M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.27M	51.18M	15.7M	13.2M	26.55M	24.06M	13.56M	6.19M	1.9M
Total Assets	110.54M	182.39M	124.8M	171.07M	153.45M	106.1M	129.01M	93.48M	13.77M
Account Payables	7.31M	1.38M	617K	1.1M	1.16M	4.15M	3.6M	3.47M	1.14M
Deferred Revenue	368K	27.11M	10.37M	1.86M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.75M	n/a	1.69M	1.36M	947K	928K	n/a	n/a	n/a
Other Current Liabilities	34.02M	3.22M	2.97M	7.1M	7.38M	18.03M	6.34M	3.32M	3.7M
Total Current Liabilities	49.07M	37.15M	21.65M	18.67M	14.34M	26.66M	12.32M	8.16M	6.92M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	15.35M	23.69M	96K	49.35M	177K	249K	833K	365K	493K
Total Long-Term Liabilities	15.35M	38.34M	27.22M	64.11M	7.07M	4.87M	833K	365K	493K
Total Liabilities	64.42M	75.5M	48.87M	82.78M	21.41M	31.53M	13.15M	8.52M	7.41M
Total Debt	4.3M	5.54M	6.65M	7.33M	7.84M	5.54M	n/a	n/a	n/a
Common Stock	55K	53K	52K	32K	29K	19K	17K	14K	7.92M
Retained Earnings	-459.64M	-391.07M	-413.88M	-367.46M	-277.71M	-199.43M	-138.5M	-96.84M	-45.44M
Comprehensive Income	n/a	n/a	n/a	-2K	-7K	16K	-28K	-643K	-290K
Shareholders Equity	46.12M	106.89M	75.93M	88.29M	132.04M	74.57M	115.86M	84.96M	10.17M
Total Investments	n/a	46.59M	n/a	33.82M	41.7M	52.31M	81.36M	50K	50K